The effects of control of systolic and diastolic hypertension on cardiovascular and all-cause mortality in a community-based population cohort.

作者: N C Barengo , R Antikainen , M Kastarinen , T Laatikainen , J Tuomilehto

DOI: 10.1038/JHH.2013.22

关键词:

摘要: The objective of this study (follow-up 26 113 people) was to investigate differences in the risk cardiovascular disease (CVD) and all-cause mortality among hypertensive people according control systolic blood pressure (SBP) diastolic (DBP). People with a history coronary heart disease, failure, cancer or incomplete data at baseline (n=1113) were excluded from study. participants classified into six groups their status. Treated individuals controlled SBP DBP did not experience an increase compared normotensive people. 1.48-fold (95% confidence interval (CI) 1.09–2.01) those who treated antihypertensive drugs had only 1.45-fold CI 1.04–2.02) controlled. patients both have increased CVD when statistically significantly higher alone, alone uncontrolled. Our indicates that uncontrolled are factors mortality.

参考文章(37)
Clausen J, Jensen G, Blood pressure and mortality : an epidemiological survey with 10 years follow-up Journal of Human Hypertension. ,vol. 6, pp. 53- 59 ,(1992)
Henri Darquennes, Marcel Kornitzer, Luc Berghmans, R. Payen, Raphaël Lagasse, Michèle Dramaix Wilmet, The World Health Organization MONICA Project (Monitoring trends and determinants in cardiovascular disease): A major international Collaboration Journal of Clinical Epidemiology. ,vol. 41, pp. 105- 114 ,(1988)
A Zanchetti, R Cifkova, S Erdine, G McInnes, M Safar, JL Rodicio, P van Zwieten, EO Brien, EA Rosei, Jan A Staessen, F Zannad, S Kjeldsen, JM Mallion, KH Rahn, B Waeber, B Williams, K Kawecka-Jaszcs, AM Heagerty, G DeBacker, Robert Fagard, G Mancia, SG Priori, W Kiowski, LM Ruilope, T Luscher, C Farsang, NR Poulter, 2003 European society of hypertension - European Society of Cardiology guidelines for the management of arterial hypertension web science. ,vol. 21, pp. 1011- 1053 ,(2003) , 10.1097/01.HJH.0000059051.65882.32
L. WILHELMSEN, G. BERGLUND, D. ELMFELDT, G. TIBBLIN, H. WEDEL, K. PENNERT, A. VEDIN, C. WILHELMSSON, L. WERKÖ, The multifactor primary prevention trial in Göteborg, Sweden European Heart Journal. ,vol. 7, pp. 279- 288 ,(1986) , 10.1093/OXFORDJOURNALS.EURHEARTJ.A062065
F. Boudík, J. Reissigová, K. Hrach, M. Tomečková, J. Bultas, Z. Anger, M. Aschermann, J. Zvárová, Primary prevention of coronary artery disease among middle aged men in Prague: twenty-year follow-up results. Atherosclerosis. ,vol. 184, pp. 86- 93 ,(2006) , 10.1016/J.ATHEROSCLEROSIS.2005.02.011
Bruce M Psaty, Nicholas L Smith, David S Siscovick, Thomas D Koepsell, Noel S Weiss, Susan R Heckbert, Rozenn N Lemaitre, Edward H Wagner, Curt D Furberg, None, Health Outcomes Associated With Antihypertensive Therapies Used as First-Line AgentsA Systematic Review and Meta-analysis JAMA: The Journal of the American Medical Association. ,vol. 277, pp. 739- 745 ,(1997) , 10.1001/JAMA.1997.03540330061036
T HANSEN, J JEPPESEN, S RASMUSSEN, H IBSEN, C TORPPEDERSEN, Ambulatory Blood Pressure Monitoring and Risk of Cardiovascular Disease: A Population Based Study* American Journal of Hypertension. ,vol. 19, pp. 243- 250 ,(2006) , 10.1016/J.AMJHYPER.2005.09.018
C J Bulpitt, A J Palmer, A E Fletcher, D G Beevers, E C Coles, J G Ledingham, P W O'Riordan, J C Petrie, B E Rajagopalan, J Webster, Optimal blood pressure control in treated hypertensive patients. Report from the Department of Health Hypertension Care Computing Project (DHCCP). Circulation. ,vol. 90, pp. 225- 233 ,(1994) , 10.1161/01.CIR.90.1.225